Hypertonic Saline prevents progression of lung disease and formation of bronchiectasis in Cystic Fibrosis. Amazing research. Let's hope for more evidence to support its use in non-CF bronchiectasis soon!
⭐️Save the date⭐️
Please promote this to your colleagues and patients! The inaugural conference last year was fantastic! Can’t wait for this one 🫁🫁🫁
https://t.co/5Mh7FGd6oI
"Pulmonary Rehabilitation. Hospital Rehabilitation Model. Simeox Therapy in Post Covid-19 Patients".
Come join us! Click the link below to register.
WEDNESDAY, NOVEMBER 17 2021 AT 12:00 PM (GMT)
https://t.co/mOCqsVZRIp
As part of the #ECFS2021 conference program, we are proud to propose the following symposium: "Simeox therapy: a new technology for physiotherapy in CF". 👏
If you have registered to the conference, join us online on Thursday, June 10, 2021 from 10.10 to 10.45 am CEST
SAVE THE DATE!
We are very proud and excited to present our next online event: A series of 3 European Virtual Roundtables on Simeox therapy!🌿
#healthcare#event#cysticfibrosis#simeox
🌱 Here is the first publication on the benefits of Simeox in paediatric CF patients:
✨ 48 children with CF (2x24) hospitalized for pulmonary exacerbation received during 14 days Simeox device in addition to standard care (SC) or SC alone for airway clearance management... #CF
RSM Personalised Medicine in CF and Bronchiectasis.
Free to attend - Tonight 6pm https://t.co/PUMK7tqiCY
Professor James Chalmers. Professor Jane. Davies. Professor Steven Rowe. Dr George Solomon
Ooo some data, thought i'd share.
Airway clearance devices can improve exacerbation
frequency, sputum clearance, and symptoms in stable COPD.
https://t.co/y8l1t64kHm